285 related articles for article (PubMed ID: 35211833)
1. AT1 Receptors: Their Actions from Hypertension to Cognitive Impairment.
Wu H; Sun Q; Yuan S; Wang J; Li F; Gao H; Chen X; Yang R; Xu J
Cardiovasc Toxicol; 2022 Apr; 22(4):311-325. PubMed ID: 35211833
[TBL] [Abstract][Full Text] [Related]
2. Chronic administration of pharmacological doses of angiotensin 1-7 and iodoangiotensin 1-7 has minimal effects on blood pressure, heart rate, and cognitive function of spontaneously hypertensive rats.
Stoyell-Conti FF; Chabbra A; Puthentharayil J; Rigatto K; Speth RC
Physiol Rep; 2021 Apr; 9(7):e14812. PubMed ID: 33904655
[TBL] [Abstract][Full Text] [Related]
3. The intrarenal renin-angiotensin system in hypertension.
Carey RM
Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
5. Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control.
de Kloet AD; Liu M; Rodríguez V; Krause EG; Sumners C
Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(5):R444-58. PubMed ID: 26084692
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.
Szczepanska-Sadowska E; Czarzasta K; Cudnoch-Jedrzejewska A
Curr Hypertens Rep; 2018 Mar; 20(3):19. PubMed ID: 29556787
[TBL] [Abstract][Full Text] [Related]
7. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
8. Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance.
Mińczuk K; Baranowska-Kuczko M; Krzyżewska A; Schlicker E; Malinowska B
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683028
[TBL] [Abstract][Full Text] [Related]
9. Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension.
Liu C; Luo R; Wang W; Peng Z; Johnson GVW; Kellems RE; Xia Y
Am J Hypertens; 2019 Apr; 32(5):476-485. PubMed ID: 30715101
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress.
Passaglia P; Ceron CS; Mecawi AS; Antunes-Rodrigues J; Coelho EB; Tirapelli CR
Vascul Pharmacol; 2015 Nov; 74():49-59. PubMed ID: 25872164
[TBL] [Abstract][Full Text] [Related]
11. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
Balakumar P; Jagadeesh G
Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blockade and end-organ protection.
Chung O; Unger T
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):150S-156S. PubMed ID: 10619595
[TBL] [Abstract][Full Text] [Related]
13. In hypertension, the kidney rules.
Crowley SD; Coffman TM
Curr Hypertens Rep; 2007 Apr; 9(2):148-53. PubMed ID: 17442227
[TBL] [Abstract][Full Text] [Related]
14. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.
Zhuo J; Moeller I; Jenkins T; Chai SY; Allen AM; Ohishi M; Mendelsohn FA
J Hypertens; 1998 Dec; 16(12 Pt 2):2027-37. PubMed ID: 9886893
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.
Crowley SD; Gurley SB; Herrera MJ; Ruiz P; Griffiths R; Kumar AP; Kim HS; Smithies O; Le TH; Coffman TM
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17985-90. PubMed ID: 17090678
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptors in the kidney and vasculature in hypertension and kidney disease.
Rianto F; Hoang T; Revoori R; Sparks MA
Mol Cell Endocrinol; 2021 Jun; 529():111259. PubMed ID: 33781840
[TBL] [Abstract][Full Text] [Related]
17. Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension.
Xue B; Zhang Z; Beltz TG; Guo F; Hay M; Johnson AK
Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H191-8. PubMed ID: 24858844
[TBL] [Abstract][Full Text] [Related]
18. Central AT1 receptor signaling by circulating angiotensin II is permissive to acute intermittent hypoxia-induced sympathetic neuroplasticity.
Shimoura CG; Andrade MA; Toney GM
J Appl Physiol (1985); 2020 May; 128(5):1329-1337. PubMed ID: 32240022
[TBL] [Abstract][Full Text] [Related]
19. Vascular angiotensin AT1 receptor neuromodulation in fetal programming of hypertension.
Vieira-Rocha MS; Rodríguez-Rodríguez P; Sousa JB; González MC; Arribas SM; López de Pablo AL; Diniz C
Vascul Pharmacol; 2019 Jun; 117():27-34. PubMed ID: 30326265
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II and AT
Leite APO; Li XC; Nwia SM; Hassan R; Zhuo JL
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
